[PDF] Top 20 Importancia del uso de las herramientas pedagógicas digitales en la educación inicial
Has 10000 "Importancia del uso de las herramientas pedagógicas digitales en la educación inicial" found on our website. Below are the top 20 most common "Importancia del uso de las herramientas pedagógicas digitales en la educación inicial".
Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a
... Abstract: Multiple sclerosis (MS) is a progressive, neurodegenerative disease with unpredictable phases of relapse and ...since. Interferon β (IFNβ) was the first biologic approved after ... See full document
9
Advances in the management of relapsing–remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12)
... Standard metrics for MS clinical trials were captured; however, the primary endpoint differed between the pivotal studies. The primary endpoint in DEFINE was the propor- tion of patients with a relapse while CONFIRM ... See full document
27
Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis
... and interferon beta-1a treatment pointed out that an abnormal recruitment of the fronto-thalamic circuitry is associated with interferon-induced fatigue in MS patients ...in ... See full document
23
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
... Abstract: Multiple sclerosis (MS) is the most common autoimmune illness of the central nervous ...disease. Interferon beta (IFNβ)-1b represents the pioneer of those ...on ... See full document
62
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
... for treatment of relapsing-remitting or active secondary progressive MS, thus enlarging the spectrum of immunological therapies for this debilitating ...β 1a, and simi- lar to the efficacy of ... See full document
6
The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
... pipeline to 2D images, given their availability in this retrospective study and our previous demonstration that these images showed 1) sensitivity to disease-specific ef- fects and 2) high reproducibility [29]. We did ... See full document
11
Advances in the treatment of relapsing–remitting multiple sclerosis – critical appraisal of fingolimod
... disease. Treatment of RRMS typically consists of direct symptom management, brief corticosteroid administration for acute exacerbations, and the regular use of disease modifying drugs ...recombinant beta ... See full document
36
Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis
... Interferon beta (IFN-β) and glatiramer acetate (GA) are the primary therapeutic immunomodulatory agents that interfere with relapsing-remitting multiple sclerosis (RRMS), and the ... See full document
10
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial
... to Interferon beta for the treatment of relapsing remitting Multiple Sclerosis) study was a multicentre, randomised, double-blind, parallel-group, from outpatient clinics ... See full document
76
Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysis
... PEG-interferon beta 1a compared with interferon beta 1a for treatment of MS in Iranian ...PEG- interferon on cost of hospitalization and ...PEG-interferon ... See full document
9
Disease-modifying therapies in relapsing–remitting multiple sclerosis
... There is no clear evidence that the SC route is better than the IM route, although tolerability problems, especially related to injections and injection site reactions with the IM route (including lipoatrophy), continue ... See full document
79
Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
... and beta interferons may be ...of interferon beta-1a treated ...injecting beta inter- ...than interferon beta-1a-treated ... See full document
13
The assessment for disinvestment of intramuscular interferon beta for relapsing-remitting multiple sclerosis in Brazil
... of treatment failure, defined as treatment switching or relapse treatment or death, with the assessment showing that IFN-b-1a-IM was inferior to the other IFN-bs and to glatiramer acetate in ... See full document
7
Comparison of efficacy and safety of oral agents for the treatment of relapsing–remitting multiple sclerosis
... β 1a, interferon beta 1a; ILD, Interstitial lung disease; MMF, monomethyl fumarate; MRI, magnetic resonance imaging; MS, multiple sclerosis; MSFC, multiple ... See full document
6
Review of daclizumab and its therapeutic potential in the treatment of relapsing–remitting multiple sclerosis
... with interferon beta in active relapsing MS ...with relapsing MS who were on interferon beta therapy were randomized in a 1:1:1 manner to receive daclizumab therapy at high ... See full document
24
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
... for relapsing-remitting multiple ...them, interferon (IFN) beta remains a valid treatment approach because of its good ben- efit/risk ...IFN beta is limited by ... See full document
470
PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
... for relapsing– remitting multiple sclerosis (MS) exhibits proven, but limited, efficacy and increased side effects due to the need of frequent application of the ...PEG-IFN ... See full document
66
Deciphering the role of DNA methylation in multiple sclerosis: emerging issues
... In MS, a great effort of collaborative studies has been made in the last decade to define the genetic architecture of MS. These efforts have yielded, till now, 110 genetic risk factors of MS [9]. However, these variants ... See full document
74
An Atypical Presentation of Multiple Sclerosis
... Multiple Sclerosis (MS) involves an immune mediated process in which an abnormal response of the body’s immune system is directed against the central nervous system ...(CNS). Multiple ... See full document
18
Nuclear factor erythroid 2 related factor 2 is a critical target for the treatment of glucocorticoid resistant lupus nephritis
... reported by Biogen Inc. [21], whereas the dose of pred- nisolone was equal to that in the previous reports [28, 29]. All of the vehicle-administered mice (n = 7) devel- oped LN to varied extent. In contrast, none of the ... See full document
10
Related subjects